Red Wine Pill: FDA takes a closer look
Posted On October 31, 2008
Good for the FDA. They stepped up and smacked down a Georgia-based supplements manufacturer for making unfounded (read, rediculous) drug claims about one of its resveratrol pills. Read the report here.
The FDA told the company, Natural Biology, that its Red Wine
Resveratrol pills were being marketed as a cure and therefore violated the Federal Food, Drug, and Cosmetic Act which controls such claims.For example, this miracle pill was said to fix the following:
· Anti-cancer, anti-viral and anti-inflammatory claims (by inhibiting cyclooxygenase-1 (COX-1))
· Improved insulin signaling for those with diabetes
· Improved fat metabolism
· Controls high blood pressure
· Inhibits blood clots
· Reduces risk of breast cancer
· Causes aptosis (death of cancer cells)
· Reduces the risk of prostate cancer
· Works as anti-depressant
· Anti-cancer, anti-viral and anti-inflammatory claims (by inhibiting cyclooxygenase-1 (COX-1))
· Improved insulin signaling for those with diabetes
· Improved fat metabolism
· Controls high blood pressure
· Inhibits blood clots
· Reduces risk of breast cancer
· Causes aptosis (death of cancer cells)
· Reduces the risk of prostate cancer
· Works as anti-depressant
The FDA said this elixer vitae blatantly marketed itself as a cancer cure on the company website, including a section called ‘Health News and Research’, where reference was made to scientific papers.
There are so many times when the FDA is forced — after the fact — to recall products that have oversold themselves, or turn out to be harmful, that it is good to see them take these misleading claims to task, right up front.
(Visited 1 times, 1 visits today)
About The Author
